Evidence map›Paper›PMID 18539533›Full record

ArticleTuberculosis (Edinburgh, Scotland)2008

The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface.

Sylvain Pitarque, Gérald Larrouy-Maumus, Bruno Payré, Mary Jackson, Germain Puzo, Jérôme Nigou

Open access · greenAbstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Deletion of theFrontiers in microbiology · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. TheThe Biochemical journal · 2019
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Sylvain PitarqueInstitut de Pharmacologie et de Biologie Structurale, CNRS UMR 5089, Département Mécanismes Moléculaires des Infections Mycobactériennes, 205 Route de Narbonne, 31077 Toulouse Cedex 4, France.
Gérald Larrouy-Maumus
Bruno Payré
Mary Jackson
Germain Puzo
Jérôme Nigou
Centre National de la Recherche Scientifique · FRInstitut de Pharmacologie et de Biologie Structurale · FRInstitut Pasteur · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

Biogenesis of Lipoarabinomannan in MycobacteriaR01AI064798 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI JACKSON, MARY · 2005 to 2019
$5.4M
NIAID NIH HHS 5R01AI064798-NIAID NIH HHS N01 AI040091NIAID NIH HHS N0-1-AI-40091NIAID NIH HHS R01 AI064798
6 · The paper itself

Abstract

By labeling surface carbohydrates, we found that a pool of lipoglycans, cell wall associated, is exposed at the cell surface of mycobacteria and thus, most probably, inserted in the outer leaflet of the outer membrane. In contrast, plasma membrane anchored lipoglycans are not accessible to surface labeling. This result supports the role of lipoglycans as key immunomodulatory molecules but raises the question of their transport from the plasma membrane, where they are synthesized, to the outermost layers of the envelope, where they can act as modulins. The data are discussed in terms of consequences for cell envelope organization.

Indexed as

BiotinCell MembraneHumansLipopolysaccharidesMembrane GlycoproteinsMycobacterium tuberculosisVitamin B ComplexBiotinlipoarabinomannanlipomannanLipopolysaccharidesMembrane GlycoproteinsVitamin B Complex

Identifiers

PMID18539533
PMCPMC2613510
OpenAlexW2090939526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.